GRIFOLS | GRF - Operating Profit


GRIFOLS reported EUR329M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Alcon AG USD 297M 16M Mar/2026
Almirall EUR 71.55M 41.32M Jun/2026
Amadeus IT EUR 478.3M 12.8M Jun/2026
Amarin USD -2.26M 564K Dec/2025
argenx SE USD 493M 99M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Cie Automotive EUR 264.84M 21.12M Dec/2025
Demant DKK 2.09B 224M Dec/2025
Ence Energia y Celulosa EUR -34.9M 2.37M Mar/2026
Essilor EUR 2.3B 919M Jun/2026
Ferrovial EUR 294M 293M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 268M 395M Mar/2026
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Inditex EUR 1.76B 298M Mar/2026
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Philips EUR 610M 308M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
Smith & Nephew USD 505M 65M Jun/2026
UCB EUR 1.29B 571M Dec/2025
Viscofan EUR 49.55M 7.38M Jun/2026